2 terminated. 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Terminated 2 |
| Phase 2 | 1 | Terminated 1 |
Follow Major Depression: new trials by email Literature Review of Major Depression trials Research Report on Major Depression
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Omega 3 FA Supplements as Augmentation in the Treatment of Depression Desvenlafaxine, Omega 3 Fatty acids, Placebo (for Omega 3 fatty acid supplement) - Major Depression, Cancer | Phase 2 / Phase 3 | Terminated | UConn Health | 6 | 2013-02-01 | 2017-12-27 |
| Efficacy and Safety of Homeopathy for Moderate Depression (Acute Phase) homeopathic q-potencies, Placebo, homeopathic case history taking type I - Major Depression | Phase 3 | Terminated | Charite University, Berlin, Germany | 44 | 2010-08-01 | 2012-07-10 |
Depression (2) · Depressive Disorder, Major (2) · Cardiovascular Diseases (1) · Diabetes Mellitus (1) · Hypertension (1) · Neoplasms (1)
Behavior (2) · Behavioral Symptoms (2) · Depressive Disorder (2) · Mental Disorders (2) · Mood Disorders (2) · Endocrine System Diseases (1) · Glucose Metabolism Disorders (1) · Metabolic Diseases (1) · Nutritional and Metabolic Diseases (1) · Vascular Diseases (1)
Desvenlafaxine Succinate (1) · Fatty Acids, Omega-3 (1)
Charite University, Berlin, Germany (1) · UConn Health (1)
Germany (1) · United States (1)
Claudia M. Witt, MD (1) · Jayesh Kamath, MD PhD (1)
2009 (1)